U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT03998449) titled 'Immunogenicity of Cholera Vaccine in Children With IBD' on June 24.
Brief Summary: Assessment of the immunogenicity and safety of immunization against cholera in children with inflammatory bowel disease.
Study Type: Interventional
Condition: * Cholera
* Inflammatory Bowel Diseases
Intervention: Biological: Vaccination against cholera
Participants will receive two doses of an oral cholera vaccine with an interval of 2-4 weeks.
Recruitment Status: Recruiting
Sponsor: Medical University of Warsaw
Information provided by (Responsible Party): Lukasz Dembinski, Medical University of Warsaw
Published by HT Digital Content Services...